Ingo Eitel

Showing 1-10 of 10 articles

Interventions for valvular disease

Deep sedation versus general anaesthesia for transcatheter mitral valve repair: an individual patient data meta-analysis of observational studies

Jobs A, Grund S, de Waha-Thiele S, Ledwoch J, Sievert H, Rassaf T, Luedike P, Kelm M, Hellhammer K, Horn P, Westenfeld R, Patzelt J, Langer H, Lurz P, Desch S, Eitel I, Thiele H

March 19, 2021 | 10.4244/EIJ-D-20-00607

Reply to the letter to the editor "The impact of chronic total occlusion in non-infarct-related coronary arteries"

Saad M, Fuernau G, Eitel I, Thiele H

June 12, 2019 | 10.4244/EIJ-D-18-00787R

Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial

Saad M, Fuernau G, Desch S, Eitel I, de Waha S, Poss J, Ouarrak T, Schneider S, Zeymer U, Thiele H

June 14, 2018 | 10.4244/EIJ-D-17-00451

Coronary interventions

ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis

Orban M, Limbourg T, Neumann F, Ferenc M, Olbrich H-G, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Poss J, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H, Hausleiter J

December 9, 2016 | 10.4244/EIJY15M12_04

Interventions for heart failure

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock – results from a real-world cohort

de Waha S, Fuernau G, Eitel I, Desch S, Thiele H

June 20, 2016 | 10.4244/EIJV12I3A71

Interventions for valvular disease

Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence

Schlotter F, de Waha S, Eitel I, Desch S, Fuernau G, Thiele H

May 16, 2016 | 10.4244/EIJV12I1A17

Interventions for heart failure

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort

de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H

March 18, 2016 | 10.4244/EIJV11I12A265

Incidence, predictors, and treatment options of critical limb ischaemia after use of collagen plug-based vascular closure devices

Amer O, Binger S, Desch S, Harnoss H, Schuler G, Thiele H, Eitel I

November 20, 2015 | 10.4244/EIJV11I7A166

Incidence, characteristics and functional implications of cerebral embolic lesions after the MitraClip procedure

Blazek S, Lurz P, Mangner N, Fuernau G, Seeburger J, Luecke C, Gutberlet M, Ender J, Desch S, Eitel I, Schuler G, Thiele H

February 20, 2015 | 10.4244/EIJY14M05_10

Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials

Piccolo R, Eitel I, Iversen A, Gu Y, Dominguez-Rodriguez A, de Smet B, Mahmoud K, Abreu-Gonzalez P, Thiele H, Piscione F

January 20, 2014

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.